Scleroderma Basics: Overview, Symptoms, and Causes
Systemic scleroderma, also called systemic sclerosis, affects many parts of the body. This is the more serious type of scleroderma and can damage your blood vessels and internal organs, such as the heart, lungs, and kidneys.
What Is Scleroderma? Symptoms & Causes| NIAMS
Systemic scleroderma, also called systemic sclerosis, affects many systems in the body. This is the more serious type of scleroderma and can damage your blood vessels and internal organs, such as the heart, lungs, and kidneys.
Scleroderma Genomics and Health Disparities Unit | NIAMS
Scleroderma (systemic sclerosis) is a chronic, multi-system, autoimmune disease characterized by progressive fibrosis of the skin and internal organs. There is a health disparity in African Americans, who have an increased prevalence of scleroderma compared to European Americans.
systemic sclerosis sine scleroderma - Scleroderma - Inspire
2010年2月20日 · Thank you for your post. Not sure what IVIG is. Keep hoping and persevering. Keep in touch, and we can compare treatments. I am to go back to Cleveland Clinic in March. My email is [email protected] in the case that you or anyone with systemic sclerosis sine scleroderma want to compare treatments. Thank you. mary
Scleroderma: Diagnosis, Treatment, and Steps to Take
Almost all people with systemic scleroderma have some loss of lung function. Some people develop severe lung disease, which comes in two forms: Pulmonary fibrosis, a hardening or scarring of lung tissue because of excess collagen. Pulmonary hypertension, high blood pressure in the artery that carries blood from the heart to the lungs.
Just to clear up some confusion about scleroderma and ... - Inspire
2017年10月26日 · Ok. There seems to be a lot of confusion about what "remission" is for systemic sclerosis. Systemic sclerosis can affect any organ in the body. The hallmark presentation of the disease is the skin and this is what the Modified Rodnan Skin Score (MRSS) is widely accepted to be the determining factor of the severity of the disease.
NIAMS IRP Presentations at the 2024 ACR Convergence Conference
2024年11月14日 · Abstracts: Systemic Sclerosis & Related Disorders – Clinical II (2641–2646) 2646: Rare Variants in the IL1RAP Gene Implicate the IL-1 Signaling Pathway in the Pathogenesis of Systemic Sclerosis in African and European Ancestries
Akiko Sekiguchi, M.D., Ph.D. | About NIAMS | NIAMS
2024年3月1日 · Akiko Sekiguchi received her Ph.D. in Dermatology. She studies the mechanisms of pressure ulcers and develops new treatments for these diseases. She is also interested in autoimmune diseases, such as systemic sclerosis and dermatomyositis. In the past, Dr. Sekiguchi conducted vigorous studies of skin wound healing, including pressure ulcers.
Pravitt Gourh, M.D. | About NIAMS | NIAMS
2024年11月12日 · He has served in various roles at the American College of Rheumatology (ACR) and received multiple awards, including the Carwile Leroy/Joseph Korn Prize for Research in Scleroderma, the Young Investigator Award at the 10th International Systemic Sclerosis Workshop, the ACR Research and Education Foundation Abbott Medical and Pediatric …
Question About Systemic Sclero Antibody Levels (ACA & SCL-70)
2024年5月9日 · I must sound like a real idiot for asking, but I’m nervous about having paresthesia on my upper arms (outside the “limited scleroderma” boundaries), heart palpitations, and a high CRP of 19 in Feb and 13 in April. Those things seem to point away from limited/less severe sclerosis; compounding that, my symptoms aren’t consistent with CREST.